Blog
RSS FeedPosted by Michael Wonder on 20 Jul 2018
Proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)
20 July 2018 - PHARMAC is seeking feedback on a proposal to fund a pangenotypic treatment for chronic hepatitis C ...
Posted by Michael Wonder on 19 Jul 2018
New Zealand to expand PHARMAC to the Pacific
19 July 2018 - New Zealand is looking at opening up access to its drug buying agency PHARMAC to five Pacific ...
Posted by Michael Wonder on 16 Jul 2018
PHARMAC work in funding medicines for rare disorders progressing
16 July 2018 - PHARMAC is progressing work aimed at improving funded access to medicines for rare disorders. ...
Posted by Michael Wonder on 12 Jul 2018
New Zealand’s medicines waiting list: international disgrace for patient equity
12 July 2018 - The medicines waiting list grows to over 100 priority medicines that wait to be publicly funded ...
Posted by Michael Wonder on 11 Jul 2018
Cannabis medication for kids with epilepsy can cost 'up to $100k'
11 July 2018 - Parents of children with severe epilepsy say the cost of marijuana-based medications is a barrier to potentially ...
Posted by Michael Wonder on 08 Jul 2018
Notification of dates for entecavir brand switch
9 July 2018 - PHARMAC has announced the listing date and transition timeframes for a brand switch for entecavir from ...
Posted by Michael Wonder on 06 Jul 2018
Decision to widen access and change the funded enzyme replacement therapy for Gaucher disease
6 Jul 2018 - PHARMAC is pleased to announce changes to the funding of enzyme replacement therapy used in the ...
Posted by Michael Wonder on 04 Jul 2018
New osteoporosis treatment set to provide another option for patients
5 July 2018 - Another press release from PHARMAC announcing the listing of a new medicine that should have occurred ...
Posted by Michael Wonder on 02 Jul 2018
Another multi-product proposal from Novartis, this time involving ten pharmaceuticals
2 July 2018 - PHARMAC is seeking feedback on a proposal to fund five new treatments, widen access to three ...
Posted by Michael Wonder on 30 Jun 2018
New Zealand Pharmaceutical Schedule - 1 July 2018 update
1 July 2018 - The July 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 Jun 2018
Celebrating 25 years of PHARMAC
26 June 2018 - Health Minister Dr David Clark is pleased to mark 25 years since the establishment of the ...
Posted by Michael Wonder on 11 Jun 2018
Here’s the evidence – time to play fair PHARMAC
11 June 2018 - In light of new clinical trial results, Breast Cancer Foundation New Zealand is urging PHARMAC to ...
Posted by Michael Wonder on 08 Jun 2018
Decision to fund denosumab for osteoporosis
8 June 2018 - PHARMAC is pleased to announce a decision to fund denosumab (Prolia) for the treatment of severe, ...
Posted by Michael Wonder on 31 May 2018
New Zealand Pharmaceutical Schedule - 1 June 2018
1 June 2018 - The June 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 May 2018
Decision to remove restrictions from, and award a tender to, candesartan cilexetil
31 May 2018 - PHARMAC is pleased to announce a decision to remove the funding restrictions on candesartan cilexetil, in ...